Pediatrics international : official journal of the Japan Pediatric Society · 2016
Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sato Takeshi, Okano Tsubasa, Tanaka-Kubota Mari, Kimura Shunsuke, Miyamoto Satoshi, Ono Shintaro, Yamashita Motoi, Mitsuiki Noriko, Takagi Masatoshi, Imai Kohsuke, Kajiwara Michiko, Ebato Takasuke, Ogata Shohei, Oda Hirotsugu, Ohara Osamu, Kanegane Hirokazu, Morio Tomohiro
Аннотация
Severe combined immunodeficiency (SCID) is the most severe form of primary immunodeficiency disease, and it is characterized by marked impairment in cellular and humoral immunity. Mutations in several genes cause SCID, one of which is Janus kinase 3 (JAK3), resulting in autosomal recessive T(-)B(+)NK(-) SCID. Only three patients with JAK3-deficient SCID have been reported in Japan. We herein describe the case of a 6-month-old girl with pneumocystis pneumonia, who was diagnosed with SCID with compound heterozygous JAK3 mutations (c.1568G>A + c.421-10G>A). One of the mutations was previously reported in another Japanese patient. The other mutation was a novel and de novo relatively deep intronic mutation causing aberrant RNA splicing. The patient was successfully treated with bone marrow transplantation from a haploidentical donor.